ABSTRACT
In temperate regions, respiratory viruses such as SARS-CoV-2 are better transmitted in Winter than in Summer. Understanding how temperature and humidity affect SARS-CoV-2 transmissibility can enhance projections of COVID-19 incidence and improve estimation of the effectiveness of control measures. During the pandemic, transmissibility was tracked by the reproduction number Rt. This study aims to determine whether information about the daily temperature and absolute humidity improves predictions of Rt in the Netherlands from 2020 to 2022, and to quantify the relationship between Rt, daily temperature and absolute humidity. We conducted a regression analysis, accounting for immunity from vaccination and previous infection, higher transmissibility of new variants, and changes in contact behaviour due to control measures. Results show a linear association between logRt and daily temperature, indicating a ratio of Rt in Winter versus Summer of 1.5 (95% CI, 1.2-1.8). Including absolute humidity in the model did not improve predictions. The possibility that this association arises from unrelated seasonal patterns was dismissed, as weather data from earlier years provided poorer fits, and incorporating mobility data did not affect results. This suggests a causal relationship between temperature and SARS-CoV-2 transmissibility, enhancing confidence in using this relationship for short-term predictions and other epidemiological analyses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data (and code) used for this study are available online at github.com/rivm-syso/covid-seasonality
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Data availability: all data and code are available online at github.com/rivm-syso/covid-seasonality We thank all collaborators in the Data Analytics, Research, and Automated Reporting (DARA) team in the Center for Infectious Disease Control for processing and curating all COVID-19 surveillance data.
Conflicts of Interest: none.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos